Literature DB >> 14636241

Fibroblast growth factor receptor-1 interacts with the T-cell receptor signalling pathway.

Victor M Byrd1, Dawn M Kilkenny, Michael M Dikov, Martha B Reich, Jonathan V Rocheleau, Wade J Armistead, James W Thomas, Geraldine G Miller.   

Abstract

Fibroblast growth factor receptors are expressed by some T cells, and provide costimulation for these cells. Such receptors allow T cells to respond to fibroblast growth factors expressed in response to injury and inflammation and may provide a mechanism for 'context-dependent' responses to antigens within the local microenvironment. The mechanisms by which fibroblast growth factor receptors might interact with the TCR signalling pathway are not defined. Here we show that the TCR and fibroblast growth factor receptors co-localize during combined stimulation. Signalling via fibroblast growth factor receptors alone results in phosphorylation of Lck and induces nuclear translocation of nuclear factors of activated T cells. Combined stimulation via fibroblast growth factor receptors and the TCR synergistically enhances the activation of nuclear factors of activated T cells. The results suggest that peptide growth factors produced at sites of injury and inflammation can contribute to the outcome of T-cell encounters with antigen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636241     DOI: 10.1046/j.1440-1711.2003.01199.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  8 in total

Review 1.  CHARGE syndrome: a review of the immunological aspects.

Authors:  Monica T Y Wong; Elisabeth H Schölvinck; Annechien J A Lambeck; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

2.  Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.

Authors:  Jaitip Tipanee; Ermira Samara-Kuko; Thierry Gevaert; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2022-06-16       Impact factor: 12.910

3.  Association Between Single Nucleotide Polymorphisms in NFATC1 Signaling Pathway Genes and Susceptibility to Congenital Heart Disease in the Chinese Population.

Authors:  Fengyu Wang; Haili Wang; Lina Wang; Shiyuan Zhou; Mingxiu Chang; Jiping Zhou; Yongheng Dou; Yanli Wang; Xiangdong Shi
Journal:  Pediatr Cardiol       Date:  2016-08-27       Impact factor: 1.655

4.  Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade.

Authors:  Saeed S Akhand; Zian Liu; Stephen C Purdy; Ammara Abdullah; Hang Lin; Gregory M Cresswell; Timothy L Ratliff; Michael Wendt
Journal:  Cancer Immunol Res       Date:  2020-10-22       Impact factor: 11.151

5.  Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes.

Authors:  Baojiang Chen; Chen Li; Guizhen Chang; Huan Wang
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion.

Authors:  Hannes Olauson; Karolina Lindberg; Risul Amin; Tadatoshi Sato; Ting Jia; Regina Goetz; Moosa Mohammadi; Göran Andersson; Beate Lanske; Tobias E Larsson
Journal:  PLoS Genet       Date:  2013-12-12       Impact factor: 5.917

7.  Profiling of human lymphocytes reveals a specific network of protein kinases modulated by endurance training status.

Authors:  Katharina Alack; Astrid Weiss; Karsten Krüger; Mona Höret; Ralph Schermuly; Torsten Frech; Martin Eggert; Frank-Christoph Mooren
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

8.  Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts.

Authors:  Annika Gocht; Bernd Spriewald; Jörg H W Distler; Martina Ramsperger-Gleixner; Stephan M Ensminger; Michael Weyand; Christian Heim
Journal:  Transplant Direct       Date:  2018-06-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.